Xencor | Leverandørgjeld

Created with Highcharts 10.1.0Chart context menu


Trade Creditors Endring Dato
AbbVie 2.94B 2.66B 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amgen USD 1.91B 239M 2024-12
Arrowhead Research USD 14.46M 3.07M 2024-12
AstraZeneca 22.46B 781M 2024-12
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
J&J USD 10.31B 1.36B 2024-12
MacroGenics USD 6.61M 1.38M 2024-09
Merck USD 4.08B 493M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Roche Holding 4.35B 828M 2024-12
Xencor USD 16.76M 2.01M 2024-12



Xencor Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.